Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CURB | CLSK |
|---|---|---|
| Price | $27.86 | $12.48 |
| Change today | ▼ 1.45% | ▼ 2.04% |
| Market cap | $3.20B | $3.21B |
| Return, 3 months | -8.6% | 0.0% |
| Return, year to date | +22.2% | +23.3% |
| Return, 1 year | +23.2% | -28.4% |
| P/E (TTM) | 103.2 | -3.3 |
| P/B | 1.5 | 4.2 |
| P/E percentile vs own 5y | – | 60th |
| Dividend yield | 2.37% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +27.4% | +91.1% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 37 | 44 |
| 30-day volatility | 14.9% | 75.3% |
| Max drawdown, 1 year | -11.8% | -64.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
